PL2049132T3 - Nowe środki do leczenia zaburzeń związanych z osłabionym neuroprzekaźnictwem - Google Patents

Nowe środki do leczenia zaburzeń związanych z osłabionym neuroprzekaźnictwem

Info

Publication number
PL2049132T3
PL2049132T3 PL07801575T PL07801575T PL2049132T3 PL 2049132 T3 PL2049132 T3 PL 2049132T3 PL 07801575 T PL07801575 T PL 07801575T PL 07801575 T PL07801575 T PL 07801575T PL 2049132 T3 PL2049132 T3 PL 2049132T3
Authority
PL
Poland
Prior art keywords
treatment
novel agents
disorders connected
impaired neurotransmission
neurotransmission
Prior art date
Application number
PL07801575T
Other languages
English (en)
Inventor
Ann Fowler
Regina Goralczyk
Claus Kilpert
Goede Schueler
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Publication of PL2049132T3 publication Critical patent/PL2049132T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/50—Feeding-stuffs specially adapted for particular animals for rodents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/10—Cereal-derived products
    • A23L7/117—Flakes or other shapes of ready-to-eat type; Semi-finished or partly-finished products therefor
    • A23L7/126—Snacks or the like obtained by binding, shaping or compacting together cereal grains or cereal pieces, e.g. cereal bars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Food Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Nutrition Science (AREA)
  • Biotechnology (AREA)
  • Birds (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Physiology (AREA)
PL07801575T 2006-08-09 2007-08-09 Nowe środki do leczenia zaburzeń związanych z osłabionym neuroprzekaźnictwem PL2049132T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06016659 2006-08-09
EP07801575A EP2049132B1 (en) 2006-08-09 2007-08-09 Novel agents for the treatment of disorders connected to impaired neurotransmission
PCT/EP2007/007053 WO2008017484A1 (en) 2006-08-09 2007-08-09 Novel agents for the treatment of disorders connected to impaired neurotransmission

Publications (1)

Publication Number Publication Date
PL2049132T3 true PL2049132T3 (pl) 2013-05-31

Family

ID=37649511

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07801575T PL2049132T3 (pl) 2006-08-09 2007-08-09 Nowe środki do leczenia zaburzeń związanych z osłabionym neuroprzekaźnictwem

Country Status (8)

Country Link
US (1) US20100074976A1 (pl)
EP (1) EP2049132B1 (pl)
JP (2) JP5776086B2 (pl)
KR (1) KR101454039B1 (pl)
CN (2) CN105106301A (pl)
ES (1) ES2399667T3 (pl)
PL (1) PL2049132T3 (pl)
WO (1) WO2008017484A1 (pl)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110044968A (ko) * 2008-06-10 2011-05-03 디에스엠 아이피 어셋츠 비.브이. 식물 추출물 및 ｐｕｆａ 조합물
CN102186341B (zh) 2008-10-20 2013-12-25 荷兰联合利华有限公司 抗菌组合物
JP2012518618A (ja) * 2009-02-20 2012-08-16 ディーエスエム アイピー アセッツ ビー．ブイ． 機敏さのためのオレガノ抽出物
AU2010297406B2 (en) 2009-09-24 2013-10-17 Unilever Plc Disinfecting agent comprising eugenol, terpineol and thymol
FR2955782B1 (fr) * 2010-01-29 2014-02-14 Expanscience Lab Extraction solide / liquide
WO2012076310A1 (en) 2010-12-07 2012-06-14 Unilever Nv An oral care composition
ITRM20110450A1 (it) * 2011-08-26 2013-02-27 Vecchio Francesca Del Metodo apparecchiatura ingredienti e formulazioni per produrre soluzioni ad elevato effetto nutriente ricostituente antiossidante e curativo per un sistema completo ed automatizzato per prevenire e combattere la sindrome dello spopolamento delle api
MX2014005405A (es) 2011-11-03 2014-06-23 Unilever Nv Una composicion de limpieza personal.
JP2013194031A (ja) * 2012-03-22 2013-09-30 Inabata Koryo Kk 骨形成促進剤
JP5986793B2 (ja) * 2012-04-26 2016-09-06 小川香料株式会社 セイボリーエキスの製造方法
KR101493139B1 (ko) * 2013-01-08 2015-02-13 경상대학교산학협력단 타이모퀴논 및 비타민 c를 유효성분으로 포함하는 신경세포 보호용 조성물
US20140301959A1 (en) * 2013-03-14 2014-10-09 Elias Chavando Composition for deodorizing breath
EP3066937B1 (en) * 2013-10-09 2021-01-06 Ajinomoto Co., Inc. Foodstuff containing histidine and application therefor
US9630896B2 (en) 2013-11-22 2017-04-25 Tansna Therapeutics, Inc. 2,5-dialkyl-4-H/halo/ether-phenol compounds
CN103976986A (zh) * 2014-05-26 2014-08-13 中国药科大学 百里香酚在制备抗抑郁药物中的应用
CN106243096B (zh) * 2016-07-29 2019-11-29 上海璃道医药科技有限公司 三环类药物的新用途
WO2019055550A2 (en) * 2017-09-12 2019-03-21 Jina Pharmaceuticals, Inc. METHODS FOR PREPARING COMPOSITIONS CONTAINING THYMOQUINONE
CA3087050C (en) * 2017-12-27 2023-09-19 Sami Labs Limited Compositions containing thymohydroquinone and their method of preparation
CN108157217A (zh) * 2018-01-16 2018-06-15 淄博南庚商贸有限公司 一种猫掌套
CN108184704A (zh) * 2018-01-16 2018-06-22 淄博南庚商贸有限公司 一种犬掌套
CN108419702A (zh) * 2018-01-16 2018-08-21 淄博南庚商贸有限公司 一种兔掌套
WO2019180719A1 (en) * 2018-03-20 2019-09-26 N.S. Oils Ltd. Nigella sativa oil composition
JP2020031570A (ja) * 2018-08-29 2020-03-05 大正製薬株式会社 体内時計調整用組成物
AU2020317501B2 (en) * 2019-07-24 2024-11-14 Asahi Group Holdings, Ltd. Agent for regulating female hormone secretion and agent for alleviating unpleasant symptoms
EP4054351A4 (en) * 2019-11-08 2023-11-29 Kemin Industries, Inc. THYMOHYDROQUINONE-BASED SYSTEM FOR FOODS INTENDED FOR HUMAN AND PET ANIMALS AND ASSOCIATED METHODS
IT202000004123A1 (it) * 2020-02-27 2021-08-27 A M Italy S R L Composizione per l'uso nella terapia, in particolare per la cura della depressione
WO2021241982A1 (ko) * 2020-05-29 2021-12-02 재단법인 대구경북첨단의료산업진흥재단 N을 하나 이상 포함하는 5원자의 헤테로아릴 유도체 및 이를 유효성분으로 함유하는 정신질환의 예방 또는 치료용 약학적 조성물
CN116261462B (zh) * 2020-07-14 2024-12-13 科然药业有限公司 组合物及其用途
WO2022175263A2 (en) * 2021-02-16 2022-08-25 Dsm Ip Assets B.V. Methods of selectively promoting animal welfare through modulation of microbiome
US11911346B2 (en) 2021-08-27 2024-02-27 Nutrient Survival Llc Orally administrated therapeutic for treating mild cognitive impairment (MCI) and improving human cognitive function
CN114948915B (zh) * 2022-07-18 2023-10-24 广东省农业科学院动物卫生研究所 百里醌在制备抗副猪嗜血杆菌药物中的应用
TW202434199A (zh) * 2022-11-17 2024-09-01 美商開萌工業公司 抑制蝦ehp感染之組成物及相關方法
WO2025106694A1 (en) * 2023-11-14 2025-05-22 Kemin Industries, Inc. Compositions for treating sea lice in salmon and related methods

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2019185C1 (ru) * 1992-05-13 1994-09-15 Русанов Сергей Евгеньевич Сбор лекарственных растений, обладающий успокоительным и гипотензивным действием
AU693467B2 (en) 1993-08-20 1998-07-02 Scottish Agricultural College Beneficial effects of plant volatile oils
JPH09227399A (ja) * 1996-02-27 1997-09-02 Pola Chem Ind Inc 副腎皮質ホルモン分泌抑制剤
RU2113139C1 (ru) * 1996-07-02 1998-06-20 Курская биофабрика - фирма "БИОК" Концентрированная основа для напитка "пересвет"
JP3373738B2 (ja) * 1996-08-30 2003-02-04 ハウス食品株式会社 わさび香味調合品及びわさび風味食品
RO115120B1 (ro) * 1997-03-12 1999-11-30 Ovidiu Bojor Ceai antistres
RU2114629C1 (ru) * 1997-04-10 1998-07-10 Бабаскина Людмила Ивановна Сбор лекарственных трав, обладающий общеукрепляющим и нормализующим гормональный статус в климактерическом периоде действием
JP2000302658A (ja) * 1999-04-20 2000-10-31 Pola Chem Ind Inc 敏感肌用の皮膚外用剤
US6203796B1 (en) * 1999-07-08 2001-03-20 Andreas D. Papaprodromou Oregano-based therapeutic composition
HU222162B1 (hu) * 1999-12-22 2003-04-28 Márta Fenyő Elrendezés emberi szervezet relaxálására és a közérzet javítására
RU2174005C1 (ru) * 2000-11-09 2001-09-27 Закрытое акционерное общество "Агропромышленная фирма "Фито-ЭМ" Сбор лекарственных растений для лечения неврозов и неврастении
JP4698038B2 (ja) * 2001-02-15 2011-06-08 株式会社Adeka βグルカン含有油脂組成物を含有するベーカリー製品
US6387416B1 (en) * 2001-04-05 2002-05-14 Thomas Newmark Anti-Inflammatory herbal composition and method of use
JP2002360200A (ja) * 2001-06-08 2002-12-17 Kaneka San Spice:Kk スパイス・ハーブ入り冷凍揚げ物およびその冷凍揚げ物用衣材
JP2004002237A (ja) * 2002-05-31 2004-01-08 Noriko Yagi 老化防止ハーブ
JP2006008555A (ja) * 2004-06-24 2006-01-12 Japan Science & Technology Agency オレガノ抽出物のα−グルコシダーゼ阻害剤およびその利用
ATE460081T1 (de) * 2004-07-21 2010-03-15 Alltech Inc Zusammensetzung und ihre verwendung zur bekämpfung von protozoen-infektionen von tieren
TWI342780B (en) * 2004-08-11 2011-06-01 Access Business Group Int Llc Dietary supplement
DE102006001979A1 (de) * 2006-01-13 2007-07-19 Basf Ag Verwendung einer wässrigen Polymerzusammensetzung zum Imprägnieren von Rohpapier
WO2012075239A1 (en) * 2010-12-03 2012-06-07 Theravance, Inc. Serotonin reuptake inhibitors

Also Published As

Publication number Publication date
WO2008017484A1 (en) 2008-02-14
JP5776086B2 (ja) 2015-09-09
KR20090036579A (ko) 2009-04-14
JP2010500306A (ja) 2010-01-07
CN101500588A (zh) 2009-08-05
US20100074976A1 (en) 2010-03-25
ES2399667T3 (es) 2013-04-02
EP2049132B1 (en) 2012-12-05
EP2049132A1 (en) 2009-04-22
JP2014122215A (ja) 2014-07-03
CN105106301A (zh) 2015-12-02
KR101454039B1 (ko) 2014-10-27

Similar Documents

Publication Publication Date Title
PL2049132T3 (pl) Nowe środki do leczenia zaburzeń związanych z osłabionym neuroprzekaźnictwem
IL187168A0 (en) Improved nanobodiestm for the treatment of aggregation-mediated disorders
IL191283A (en) Compositions for treating eye irregularities
ZA200806074B (en) Compounds for the treatment of inflammatory disorders
IL197118A0 (en) Ultrasonic treatment of glaucoma
ZA200707591B (en) Dihyrothienopyrimidines for the treatment of inflammatory diseases
IL195906A0 (en) Alpha-aminoamide derivatives useful in the treatment of cognitive disorders
EP1976377A4 (en) COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
EP1983972A4 (en) COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
EP2019673A4 (en) COMPOUNDS FOR THE TREATMENT OF METABOLISM DISORDER
ZA200901523B (en) Use of extracts for the treatment of viral disorders
ZA200903772B (en) Treatment of pervasive developmental disorders
IL194189A0 (en) Combination treatment of metabolic disorders
ZA200806455B (en) Use of 2-imidazoles for the treatment of CNS disorders
EP1976378A4 (en) COMPOUNDS FOR THE TREATMENT OF METABOLISM DISORDER
IL192877A0 (en) Use of 2-imidazoles for the treatment of cns disorders
IL192933A0 (en) Benzoisoindole derivatives for the treatment of pain
IL192851A0 (en) Compounds for the treatment of metabolic disorders
IL198432A0 (en) 2-alkyl-indazole compounds for the treatment of certain cns-related disorders
EP1978948A4 (en) COMPOUNDS FOR THE TREATMENT OF METABOLISM DISORDER
GB0602857D0 (en) The treatment of sialorrhoea
GB0618705D0 (en) Treatment of joint disorders
BRPI0716580A2 (pt) Tratamento de distúrbios fibrosantes
GB0619218D0 (en) Treatment of conformational disorders
GB0601091D0 (en) The Treatment Of Ocular Conditions